Immunology
News
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
News
FDA pulls U.S. authorization for Eli Lilly’s COVID drug bebtelovimab
The drug is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
News
Buzzy Lancet long COVID paper under investigation for ‘data errors’
A reader found inconsistencies between the data in the article and a later paper describing the same cohort of patients after a year of follow-up...
News
More vaccinated people dying of COVID as fewer get booster shots
But the case for the effectiveness of vaccines and boosters versus skipping the shots remains strong.
News
Experts explain the ‘perfect storm’ of rampant RSV and flu
“Decreased exposure to endemic viruses created an immunity gap – a group of susceptible individuals who avoided infection and therefore lack...
News
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
An ongoing phase 2 trail shows the vaccine offered the strongest protection in people older than 55 years.
News
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
Evusheld preexposure prophylaxis shows promise in protecting certain immunocompromised patients from severe COVID-19, Cleveland Clinic researchers...
Commentary
Is another COVID-19 booster really needed?
Vaccinate the elderly (and some middle aged too, if possible) and the frail as soon as possible with any version of the booster you have available...
News
When is an allergic reaction to raw plant food due to tree pollen?
Allergy tests may be needed for people who report atypical or severe reactions or who also react to cooked or processed plant foods.
News
Many young kids with COVID may show no symptoms
The relationship between symptoms and viral load also differed between adults and young children in a new study.